Abstract:Objective: This study aimed to investigate the protective effect and mechanism of Astragalus polysaccharide (APS) on autoimmune encephalomyelitis. Methods: C57BL/6 mice were randomly divided into the blank control group, EAE group, and APS intervention group (n=15/group). The Experimental Autoimmune Encephalomyelitis (EAE) mouse model was established by active immunization. The pathological changes in the spinal cord were evaluated by Hematoxylin-eosin (HE) and Luxol Fast Blue (LFB) staining. The number of CD11b+ Gr-1+ myeloid-derived suppressor cells (MDSCs) in the spleen tissues of mice in each group was determined by immunofluorescence staining. The expression of Arginase-1 in the spinal cord and spleen of each group was detected by immunofluorescence double staining. The TNF-α, IL-6, and Arginase-1 levels in the spleen were detected by ELISA assay. A western blot was used to detect the protein expression of the AMPK/JAK/STAT3/Arginase-1 signaling pathway. Results: After the intervention of APS, the incidence of autoimmune encephalomyelitis in mice of the APS group was significantly lower than that in the EAE group, and the intervention of APS could significantly delay the onset time in the EAE mice, and the score of neurological function deficit in mice was significantly lower than that in EAE group (P < 0.05). APS intervention could reduce myelin loss and improve the inflammatory response of EAE mice. Moreover, it could induce the expression of CD11b+ GR-1 + bone MDSCs in the spleen and increase the expression of Arginase-1 in the spinal cord and spleen. This study further demonstrated that APS can protect EAE mice by activating the AMPK/JAK/STAT3/Arginase-1 signaling pathway. Conclusion: After the intervention of APS, myelin loss and inflammatory response of EAE mice were effectively controlled. APS promoted the secretion of Arginase-1 by activating MDSCs and inhibited CD4+T cells by activating AMPK/JAK/STAT3/Arginase-1 signaling pathway, thus improving the clinical symptoms and disease progression of EAE mice.

Effects of Different Molecule Weight Astragalus Polysacharin Isolated from Annual Astragalus Membra-Neaceus on Experssions of Inflammatory Cytokines in RAW264.7 Cells

Astragalus Polysaccharide Induces Anti-Inflammatory Effects Dependent On Ampk Activity In Palmitate-Treated Raw264.7 Cells

Astragalus polysaccharides down-regulate expression of α-SMA in airway smooth muscle cells

Structural Characterization and Screening for Anti‐inflammatory Activity of Polysaccharides with Different Molecular Weights from Astragali Radix

Astragalus polysaccharide reduces inflammatory response by decreasing permeability of LPS-infected Caco2 cells.

The Protective Effect of Astragalus Polysaccharide on Experimental Autoimmune Encephalomyelitis in Mice by Activating the AMPK/JAK/STAT3/Arginase-1 Signaling Pathway

<i>Astragalus polysaccharides</i> alleviates LPS-induced inflammation via the NF-B/MAPK signaling pathway

Effect of astragalus polysaccharides on IL-1,NO and TNF-α secreted by lipopolysaccharid induced normal piglets peritoneal macrophages

Structure Characterization of Honey-Processed Astragalus Polysaccharides and Its Anti-Inflammatory Activity In Vitro

Sulfated Astragalus Polysaccharide Can Regulate the Inflammatory Reaction Induced by LPS in Caco2 Cells

The effect of astragapolysaccharide on the lymphocyte proliferation and airway inflammation in sensitized mice

Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo

Astragalus polysaccharides alleviates lipopolysaccharides-induced inflammatory lung injury by altering intestinal microbiota in mice

Study of Astragalus polysaccharide with different molecular amount on secretion of defensions and adhesion in intestinal tract

Effects of Astragalus Polysaccharide on Airway Remodelling in the Asthma Modle of Mouse

Astragalus Polysaccharide Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Microglial Cells: Regulation of Protein Kinase B and Nuclear Factor-Κb Signaling.

Effects of Astragalus Polysaccharides on Osteoarthritis in Rats

Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway

Astragalus Polysaccharides Attenuate Ovalbumin-Induced Allergic Rhinitis in Rats by Inhibiting NLRP3 Inflammasome Activation and NOD2-Mediated NF- κ B Activation

Effects of Astragalus polydsaccharide on proliferation of SPC-A-1

Potential effect of astragaloside IV on the lipopolysaccharide induced inflammation via the inactivation of NF-κB signaling pathway